Matches in Wikidata for { <http://www.wikidata.org/entity/Q83064605> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q83064605 description "article scientifique publié en 2010" @default.
- Q83064605 description "artículu científicu espublizáu en febreru de 2010" @default.
- Q83064605 description "im Februar 2010 veröffentlicher wissenschaftlicher Artikel" @default.
- Q83064605 description "scientific article published on 25 February 2010" @default.
- Q83064605 description "wetenschappelijk artikel" @default.
- Q83064605 description "наукова стаття, опублікована в лютому 2010" @default.
- Q83064605 name "Normal Tissue Complication Probability after hypofractionation increased due to the high dose per fraction or the high total Biological Equivalent Dose?" @default.
- Q83064605 name "Normal Tissue Complication Probability after hypofractionation increased due to the high dose per fraction or the high total Biological Equivalent Dose?" @default.
- Q83064605 type Item @default.
- Q83064605 label "Normal Tissue Complication Probability after hypofractionation increased due to the high dose per fraction or the high total Biological Equivalent Dose?" @default.
- Q83064605 label "Normal Tissue Complication Probability after hypofractionation increased due to the high dose per fraction or the high total Biological Equivalent Dose?" @default.
- Q83064605 prefLabel "Normal Tissue Complication Probability after hypofractionation increased due to the high dose per fraction or the high total Biological Equivalent Dose?" @default.
- Q83064605 prefLabel "Normal Tissue Complication Probability after hypofractionation increased due to the high dose per fraction or the high total Biological Equivalent Dose?" @default.
- Q83064605 P1433 Q83064605-574BBBF0-1596-4475-9171-27EEB7EFAB96 @default.
- Q83064605 P1476 Q83064605-1C2299F2-553F-4600-9924-468209BC095D @default.
- Q83064605 P2093 Q83064605-265867BF-EBF0-4F1F-9C6C-6E0486695C09 @default.
- Q83064605 P2093 Q83064605-7CD43595-E1F6-4A97-AB35-9B661A737869 @default.
- Q83064605 P2093 Q83064605-8C5E79A6-B142-40FC-A831-3D030B400F15 @default.
- Q83064605 P2093 Q83064605-8CB0A7A5-41AC-4CAA-9A15-2C6D1CFB2D5F @default.
- Q83064605 P304 Q83064605-61A24932-01EB-4541-959E-454874B29CC3 @default.
- Q83064605 P31 Q83064605-27607118-ECCB-42CF-95B3-CFDD7C62821D @default.
- Q83064605 P356 Q83064605-AA051877-3E16-4E83-926E-F1AB67D2FB34 @default.
- Q83064605 P433 Q83064605-21D24DA7-C2C4-476B-82B2-526A8B116CB4 @default.
- Q83064605 P478 Q83064605-9AB2968A-1BC1-4BA0-AF84-0F3B532D24E5 @default.
- Q83064605 P577 Q83064605-862929F7-8C9F-46BD-872D-0D3514913505 @default.
- Q83064605 P698 Q83064605-C40948A0-57C0-4AA8-80A2-444FAB028261 @default.
- Q83064605 P356 J.RADONC.2010.01.023 @default.
- Q83064605 P698 20189257 @default.
- Q83064605 P1433 Q14251029 @default.
- Q83064605 P1476 "Normal Tissue Complication Probability after hypofractionation increased due to the high dose per fraction or the high total Biological Equivalent Dose?" @default.
- Q83064605 P2093 "Gerben R Borst" @default.
- Q83064605 P2093 "Jan-Jakob Sonke" @default.
- Q83064605 P2093 "Joos V Lebesque" @default.
- Q83064605 P2093 "Jose S Belderbos" @default.
- Q83064605 P304 "388" @default.
- Q83064605 P31 Q13442814 @default.
- Q83064605 P356 "10.1016/J.RADONC.2010.01.023" @default.
- Q83064605 P433 "3" @default.
- Q83064605 P478 "94" @default.
- Q83064605 P577 "2010-02-25T00:00:00Z" @default.
- Q83064605 P698 "20189257" @default.